Publications by authors named "P Hulo"

Claim this Profile
[
[Diffuse interstitial lung disease induced by antibody-drug conjugates].
L Maurier, A-L Chéné, P Hulo, J Chen, C Sagan

Rev Mal Respir· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient.
Elvire Pons-Tostivint, Pauline Hulo, Christine Sagan, Thomas Papazyan, Guillaume Herbreteau

Respir Med Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[National survey of Advanced Practice Nurses in oncology-haematology: Evaluation of activity and continuing education].
Elvire Pons-Tostivint, Laure De Decker, Gaëlle Haudebert, Pauline Hulo, Jeanne Chen

Bull Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.
Pauline Hulo, Sophie Deshayes, Judith Fresquet, Anne-Laure Chéné, Stéphanie Blandin

Respir Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
E Pons-Tostivint, P Hulo, V Guardiolle, L Bodot, A Rabeau

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis